Selective induction of calcineurin activity and signaling by oligomeric amyloid beta

Alzheimer's disease (AD) is a terminal age‐associated dementia characterized by early synaptic dysfunction and late neurodegeneration. Although the presence of plaques of fibrillar aggregates of the amyloid beta peptide (Aβ) is a signature of AD, evidence suggests that the preplaque small oligomeric Aβ promotes both synaptic dysfunction and neuronal death. We found that young Tg2576 transgenic mice, which accumulate Aβ and develop cognitive impairments prior to plaque deposition, have high central nervous system (CNS) activity of calcineurin (CaN), a phosphatase involved in negative regulation of memory function via inactivation of the transcription factor cAMP responsive element binding proteins (CREB), and display CaN‐dependent memory deficits. These results thus suggested the involvement of prefibrillary forms of Aβ. To investigate this issue, we compared the effect of monomeric, oligomeric, and fibrillar Aβ on CaN activity, CaN‐dependent pCREB and phosphorylated Bcl‐2 Associated death Protein (pBAD) levels, and cell death in SY5Y cells and in rat brain slices, and determined the role of CaN on CREB phosphorylation in the CNS of Tg2576 mice. Our results show that oligomeric Aβ specifically induces CaN activity and promotes CaN‐dependent CREB and Bcl‐2 Asociated death Protein (BAD) dephosphorylation and cell death. Furthermore, Tg2576 mice display Aβ oligomers and reduced pCREB in the CNS, which is normalized by CaN inhibition. These findings suggest a role for CaN in mediating effects of oligomeric Aβ on neural cells. Because elevated CaN levels have been reported in the CNS of cognitively impaired aged rodents, our results further suggest that abnormal CaN hyperactivity may be a common event exacerbating the cognitive and neurodegenerative impact of oligomeric Aβ in the aging CNS.

[1]  Brian J. Bacskai,et al.  Aβ Plaques Lead to Aberrant Regulation of Calcium Homeostasis In Vivo Resulting in Structural and Functional Disruption of Neuronal Networks , 2008, Neuron.

[2]  W. K. Cullen,et al.  Amyloid β Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization , 2008, The Journal of Neuroscience.

[3]  G. Taglialatela,et al.  Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice , 2007, Neurobiology of Learning and Memory.

[4]  E. Todeva.  Networks , 2007 .

[5]  T. Foster,et al.  Calcium homeostasis and modulation of synaptic plasticity in the aged brain , 2007, Aging cell.

[6]  Bernardo L Sabatini,et al.  Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.

[7]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[8]  G. Taglialatela,et al.  Up-regulation of Bcl-2 in APP transgenic mice is associated with neuroprotection , 2007, Neurobiology of Disease.

[9]  T. Jay,et al.  Phosphorylation of CREB and DARPP‐32 during late LTP at hippocampal to prefrontal cortex synapses in vivo , 2007, Synapse.

[10]  Isabelle M. Mansuy,et al.  Protein serine/threonine phosphatases in neuronal plasticity and disorders of learning and memory , 2006, Trends in Neurosciences.

[11]  P. Lansbury,et al.  A century-old debate on protein aggregation and neurodegeneration enters the clinic , 2006, Nature.

[12]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[13]  D. Selkoe,et al.  Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers , 2006, The Journal of physiology.

[14]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[15]  R. Kayed,et al.  Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis , 2006, Neurology.

[16]  U. Kang,et al.  Membrane Depolarization Induces the Undulating Phosphorylation/Dephosphorylation of Glycogen Synthase Kinase 3β, and This Dephosphorylation Involves Protein Phosphatases 2A and 2B in SH-SY5Y Human Neuroblastoma Cells* , 2005, Journal of Biological Chemistry.

[17]  E. Blalock,et al.  Calcineurin Triggers Reactive/Inflammatory Processes in Astrocytes and Is Upregulated in Aging and Alzheimer's Models , 2005, The Journal of Neuroscience.

[18]  Ian Parker,et al.  Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.

[19]  T. Golde,et al.  The Aβ Hypothesis: Leading Us to Rationally‐Designed Therapeutic Strategies for the Treatment or Prevention of Alzheimer Disease , 2005, Brain pathology.

[20]  S. Josselyn,et al.  Inducible repression of CREB function disrupts amygdala-dependent memory , 2004, Neurobiology of Learning and Memory.

[21]  Li Yang,et al.  Calcineurin-mediated BAD Ser155 dephosphorylation in ammonia-induced apoptosis of cultured rat hippocampal neurons , 2004, Neuroscience Letters.

[22]  I. Mansuy.  Calcineurin in memory and bidirectional plasticity. , 2003, Biochemical and biophysical research communications.

[23]  P. Mermelstein,et al.  Calcineurin regulation of neuronal plasticity. , 2003, Biochemical and biophysical research communications.

[24]  P. Gean,et al.  The Similarities and Diversities of Signal Pathways Leading to Consolidation of Conditioning and Consolidation of Extinction of Fear Memory , 2003, The Journal of Neuroscience.

[25]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[26]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[27]  P. Agostinho,et al.  Involvement of calcineurin in the neurotoxic effects induced by amyloid‐beta and prion peptides , 2003, The European journal of neuroscience.

[28]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[29]  T. Shimahara,et al.  Alzheimer Amyloid β-Peptide Inhibits the Late Phase of Long-Term Potentiation through Calcineurin-Dependent Mechanisms in the Hippocampal Dentate Gyrus , 2002, Neurobiology of Learning and Memory.

[30]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[31]  James P. O'Callaghan,et al.  Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP Mouse , 2002, Experimental Neurology.

[32]  Brett Chromy,et al.  Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus , 2002, Brain Research.

[33]  K Kosaka,et al.  Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. , 2001, Biochemical and biophysical research communications.

[34]  T. Foster,et al.  Calcineurin Links Ca2+ Dysregulation with Brain Aging , 2001, The Journal of Neuroscience.

[35]  J. Springer,et al.  Calcineurin-Mediated BAD Dephosphorylation Activates the Caspase-3 Apoptotic Cascade in Traumatic Spinal Cord Injury , 2000, The Journal of Neuroscience.

[36]  C. Masters,et al.  Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease , 1999, Annals of neurology.

[37]  J C Reed,et al.  Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. , 1999, Science.

[38]  Veerle Baekelandt,et al.  Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain* , 1999, The Journal of Biological Chemistry.

[39]  John Hardy,et al.  Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.

[40]  K. Deisseroth,et al.  CREB Phosphorylation and Dephosphorylation: A Ca2+- and Stimulus Duration–Dependent Switch for Hippocampal Gene Expression , 1996, Cell.

[41]  J. Brion,et al.  Calcineurin (phosphatase 2B) is present in neurons containing neurofibrillary tangles and in a subset of senile plaques in Alzheimer's disease. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[42]  D. Bennett,et al.  Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease , 1993, Neurobiology of Aging.

[43]  Stuart L. Schreiber,et al.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.

[44]  K. Kosik,et al.  Neuritic pathology and dementia in alzheimer's disease , 1991, Annals of neurology.

[45]  R. Kayed,et al.  Conformation-dependent anti-amyloid oligomer antibodies. , 2006, Methods in enzymology.

[46]  Michela Gallagher,et al.  A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.

[47]  D. Selkoe,et al.  Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.

[48]  P. Greengard,et al.  Regulation of NMDA receptor trafficking by amyloid-beta. , 2005, Nature neuroscience.

[49]  W Blaine Stine,et al.  Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. , 2002, Brain research.

[50]  D. Chao,et al.  BCL-2 family: regulators of cell death. , 1998, Annual review of immunology.

[51]  R. Abraham,et al.  Immunopharmacology of rapamycin. , 1996, Annual review of immunology.